James Investment Research’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-387
| Closed | -$224K | – | 378 |
|
|
2025
Q4 | $224K | Sell |
387
-142
| -27% | -$80.3K | 0.02% | 329 |
|
|
2025
Q3 | $257K | Sell |
529
-19
| -3% | -$8.84K | 0.03% | 307 |
|
|
2025
Q2 | $222K | Sell |
548
-16
| -3% | -$6.69K | 0.03% | 298 |
|
|
2025
Q1 | $281K | Sell |
564
-2,002
| -78% | -$1.08M | 0.04% | 275 |
|
|
2024
Q4 | $1.33M | Sell |
2,566
-2,949
| -53% | -$1.62M | 0.16% | 125 |
|
|
2024
Q3 | $3.41M | Sell |
5,515
-7
| -0.1% | -$4.14K | 0.39% | 74 |
|
|
2024
Q2 | $3.05M | Sell |
5,522
-1
| -0% | -$573 | 0.36% | 79 |
|
|
2024
Q1 | $3.21M | Sell |
5,523
-277
| -5% | -$155K | 0.38% | 80 |
|
|
2023
Q4 | $3.08M | Sell |
5,800
-1,027
| -15% | -$497K | 0.39% | 78 |
|
|
2023
Q3 | $3.46M | Sell |
6,827
-2,876
| -30% | -$1.53M | 0.46% | 69 |
|
|
2023
Q2 | $5.06M | Buy |
9,703
+298
| +3% | +$161K | 0.65% | 50 |
|
|
2023
Q1 | $5.42M | Buy |
9,405
+123
| +1% | +$69.3K | 0.72% | 40 |
|
|
2022
Q4 | $5.11M | Buy |
9,282
+306
| +3% | +$162K | 0.71% | 45 |
|
|
2022
Q3 | $4.55M | Sell |
8,976
-30
| -0.3% | -$16.8K | 0.65% | 49 |
|
|
2022
Q2 | $4.89M | Sell |
9,006
-166
| -2% | -$91.4K | 0.65% | 46 |
|
|
2022
Q1 | $5.42M | Sell |
9,172
-1,368
| -13% | -$786K | 0.57% | 56 |
|
|
2021
Q4 | $7.03M | Buy |
10,540
+308
| +3% | +$192K | 0.64% | 52 |
|
|
2021
Q3 | $5.85M | Sell |
10,232
-307
| -3% | -$168K | 0.54% | 60 |
|
|
2021
Q2 | $5.32M | Sell |
10,539
-1,276
| -11% | -$602K | 0.46% | 69 |
|
|
2021
Q1 | $5.39M | Buy |
+11,815
| New | +$5.64M | 0.49% | 67 |
|
|
2016
Q1 | – | Sell |
-140
| Closed | -$20K | – | 485 |
|
|
2015
Q4 | $20K | Hold |
140
| – | – | ﹤0.01% | 418 |
|
|
2015
Q3 | $17K | Hold |
140
| – | – | ﹤0.01% | 417 |
|
|
2015
Q2 | $18K | Hold |
140
| – | – | ﹤0.01% | 442 |
|
|
2015
Q1 | $19K | Hold |
140
| – | – | ﹤0.01% | 452 |
|
|
2014
Q4 | $18K | Hold |
140
| – | – | ﹤0.01% | 448 |
|
|
2014
Q3 | $17K | Hold |
140
| – | – | ﹤0.01% | 455 |
|
|
2014
Q2 | $17K | Sell |
140
-35
| -20% | -$4.12K | ﹤0.01% | 448 |
|
|
2014
Q1 | $21K | Hold |
175
| – | – | ﹤0.01% | 436 |
|
|
2013
Q4 | $19K | Hold |
175
| – | – | ﹤0.01% | 437 |
|
|
2013
Q3 | $16K | Buy |
175
+35
| +25% | +$3.17K | ﹤0.01% | 453 |
|
|
2013
Q2 | $12K | Buy |
+140
| New | +$11.7K | ﹤0.01% | 464 |
|
Other funds holding TMO
James Investment Research's TMO Position: Q1 2026 in Review
James Investment Research sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 387 shares — an estimated $224K sold.
James Investment Research first reported a position in TMO in Q2 2013 and held it in 31 quarters. The position peaked at $7.03M in Q4 2021. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- James Investment Research reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
- James Investment Research sold 387 Thermo Fisher Scientific shares in Q1 2026, an estimated $224K.
- James Investment Research first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 31 quarters.
- James Investment Research's Thermo Fisher Scientific position peaked at $7.03M in Q4 2021.
- 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on James Investment Research's 13F filing for Q1 2026, filed 24 Apr 2026.